[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632137":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":21,"responsibleParty":40,"collaborators":44,"id":66,"slug":10,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":10,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":10,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"exposed group",null,"Participants who receive traditional Chinese medicine (TCM) therapy for more than 60% of the total duration of their prospective follow-up period.",{"label":13,"type":10,"description":14,"interventionNames":10},"non-exposed group","Participants who do not receive any TCM therapy.",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Yuanyuan Zou, Doctor","CONTACT","+86 18080935783","zyysdmn1234@163.com",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Beijing","Beijing, China","100029","China","CN",{"type":30,"coordinates":31},"Point",[32,33],116.39723,39.9075,{"lat":33,"lon":32},[36],{"name":37,"role":18,"phone":38,"phoneExt":10,"email":39},"Yuqiao Zhang, Doctor","+86 13520678396","13661102043@163.com",{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Qingwen Tao","Chief physician",[45,47,49,51,53,55,57,60,62,64],{"name":46,"class":6},"The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine",{"name":48,"class":6},"Guangxi Ruikang Hospital",{"name":50,"class":6},"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine",{"name":52,"class":6},"Beijing Electric Power Hospital",{"name":54,"class":6},"Hunan University of Traditional Chinese Medicine",{"name":56,"class":6},"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine",{"name":58,"class":59},"Xi'an Fifth Hospital","UNKNOWN",{"name":61,"class":6},"Affiliated Hospital of Shandong University of Traditional Chinese Medicine",{"name":63,"class":6},"Shanghai University of Traditional Chinese Medicine",{"name":65,"class":59},"Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital","100632137",false,"NCT07509775","Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System","Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis: A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System","Inclusion Criteria:\n\n* fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis\n* age between 18 and 75 years\n* sign informed consent.\n\nExclusion Criteria:\n\n* diagnosis of other autoimmune diseases besides the disease under investigation (e.g., rheumatoid arthritis, Sjögren's syndrome, erythema nodosum, myositis, etc.)\n* pregnancy or lactation\n* comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or malignancy\n* spondyloarthritis related to enteropathic arthritis, psoriatic arthritis, or reactive arthritis\n* unable to provide data due to mental, language, or similar factors.","ALL","18 Years","75 Years",{"count":76,"type":77},210,"ESTIMATED","OBSERVATIONAL","This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).",[81],"Ankylosing Spondylitis (AS)","2026-04-04",{"date":84,"type":85},"2026-04-09","ACTUAL",{"date":87,"type":85},"2026-01-19",{"date":89,"type":77},"2028-06-30",{"name":5,"class":6},1]